Jan Kuś

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Soil porosity and water infiltration as influenced by tillage methods

Jerzy Lipiec, Jan Kuś, A Slowinska-Jurkiewicz et al. · Soil and Tillage Research · 2005 · 474 citations

Agriculture, Hydrology, Soil Sciences +16

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Thomas M. File, Donald E. Low, Paul B. Eckburg et al. · Journal of Antimicrobial Chemotherapy · 2011 · 196 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Rapid Subcutaneous IgG Replacement Therapy is Effective and Safe in Children and Adults with Primary Immunodeficiencies—A Prospective, Multi-National Study

Ann Gardulf, Uwe Nicolay, Òscar Asensio et al. · Journal of Clinical Immunology · 2006 · 189 citations

Life Sciences, Immunology, Pediatrics +5

Symptoms, pulmonary function, and bronchial hyperreactivity in western red cedar workers compared with those in office workers.

Moira Chan‐Yeung, Sverre Vedal, Jan Kuś et al. · PubMed · 1984 · 66 citations

Public Health, Health Sciences, Occupational Health +16